Nureca Limited (NSE:NURECA)
India · Delayed Price · Currency is INR 239.10
+2.30 (0.97%)
Jun 24, 2026, 2:43 PM IST
Nureca Revenue
In the fiscal year ending March 31, 2026, Nureca had annual revenue of 1.47B INR with 34.02% growth. Nureca had revenue of 354.05M in the quarter ending March 31, 2026, with 11.55% growth.
Revenue
1.47B
Revenue Growth
+34.02%
P/S Ratio
1.54
Revenue / Employee
8.59M
Employees
171
Market Cap
2.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.47B | 373.02M | 34.02% |
| Mar 31, 2025 | 1.10B | 177.33M | 19.29% |
| Mar 31, 2024 | 919.28M | -193.95M | -17.42% |
| Mar 31, 2023 | 1.11B | -1.44B | -56.44% |
| Mar 31, 2022 | 2.56B | 420.94M | 19.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Lyka Labs | 1.28B |
| Quest Laboratories | 1.26B |
| Vaidya Sane Ayurved Laboratories | 1.07B |
| Brooks Laboratories | 857.38M |
Nureca News
- 1 year ago - Nureca shares jump over 3% as Dr Trust & Dr Physio gear up to launch on Swiggy Instamart - Business Upturn
- 1 year ago - Nureca shares surge 6% after company signs distribution agreement - Business Upturn